An interpretable machine learning framework using multi-phase computed tomography for differentiation of adrenal lipid-poor adenomas and pheochromocytomas
The DT model strikes an optimal balance between high diagnostic accuracy and inherent interpretability, offering a practical tool that may enhance clinical confidence when managing indeterminate adrenal lesions.
Abstract
Objective To develop and validate an interpretable machine learning (ML) framework that differentiates adrenal lipid-poor adenomas (LPAs) from pheochromocytomas (PHEOs) using radiomic features derived from multi-phase contrast-enhanced computed tomography (CECT). Methods This retrospective study included 229 patients with pathologically confirmed adrenal tumours (132 LPAs, 97 PHEOs). Lesions were stratified into washout (absolute percentage washout [APW] > 60%) and non-washout (APW ≤ 60%) cohorts according to established criteria. We trained decision tree (DT), support vector machine (SVM), and logistic regression (LR) models using a predefined set of clinically relevant CT features. The inherently interpretable DT model was further dissected to revealr key discriminative features and its underlying decision logic. Model performance was evaluated using the area under the curve (AUC) with 95% confidence intervals. Results The DT model achieved excellent diagnostic performance, with an AUC of 0.977 (95% CI: 0.934–1.000) in the washout group and 0.983 (95% CI: 0.962–1.000) in the non-washout group. Feature importance analysis identified cystic degeneration as the most influential discriminator, followed by enhancement potential (EP) and baseline attenuation (CTu). The DT’s hierarchical decision rules provided clear and clinically transparent pathways. Conclusion This interpretable ML framework accurately distinguishes LPAs from PHEOs. The DT model strikes an optimal balance between high diagnostic accuracy and inherent interpretability, offering a practical tool that may enhance clinical confidence when managing indeterminate adrenal lesions.
RATIONALE AND OBJECTIVES
This study aims to develop and externally validate an interpretable machine-learning model that integrates gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging (MRI) radiomics, qualitative MRI features, and clinical data to accurately distinguish small (≤2 cm)...
To investigate the diagnostic value of machine learning models based on CT radiomics in differentiating adrenal metastases (AMs) from lipid-poor adenomas (LPAs).
A total of 212 patients with AMs and 213 patients with LPAs were retrospectively analyzed based on CT images from the First Affiliated Hospital o...
F. Zhu, Hui Wang, Heng-Feng Shi et al.· BMC Medical Imaging· 0 citations
The interpretable ENML model exhibits favorable discriminative capability for predicting poorly differentiated ESCC; however, further multicenter external validation is warranted to confirm its generalizability.
Jun Chen, Ji-Qiang He, Xiao-Jiao Zhang et al.· Frontiers in Oncology· 0 citations
The FS-T2WI radiomics can reliably and non-invasively distinguish between benign and malignant parotid tumors, while the TabResNet framework offers a practical reference for building high-performance radiomics models in clinical practice.
Xu-Ran Mao, Yan-Ting Li, Wei Zhang et al.· Journal of cranio-maxillo-fa...· 0 citations
OBJECTIVES
Accurate pre-operative prediction of Glypican-3 (GPC3) profiles in hepatocellular carcinoma (HCC) is essential for selecting candidates for targeted therapy and individualized treatment. This study aimed to develop and externally validate an explainable machine learning model for noninvasively prediction of...
Wang-Wang Lin, Chang-Kai Chen, Xue Wang· American journal of translat...· 0 citations
The interpretable radiomics-clinical model based on pretreatment mpMRI effectively predicts NAC sensitivity and RFS, offering potential to aid personalized treatment decisions.